Home › NDC Lookup › RxCUI directory › RxCUI 1048452

Colestipol hydrochloride 5000 MG Granules for Oral Suspension [Colestid] — RxCUI 1048452

RxNorm drug concept · Semantic branded drug
RxCUI 1048452 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1048452
Official nameColestipol hydrochloride 5000 MG Granules for Oral Suspension [Colestid]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asColestid 5 GM Granules For Oral Suspension; Colestid 5000 MG Oral Granules For Oral Suspension
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Colestipol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Colestipol is designed to bring down your LDL — that's the 'bad' cholesterol. It does this by working in your gut, trapping compounds called bile acids and carrying them out of you...
  • What exactly is colestipol supposed to do for me?
  • No — never take the granules or powder dry. Always stir them into a full glass of water or another beverage before you drink it. Swallowing dry powder can cause it to go down the w...
  • How do I take the granules or powder? Do I just swallow them?
📖 Read our full Colestipol guide →

🕸️ Concept Web — How Colestipol hydrochloride 5000 MG Granules for Or... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Colestipol hydrochloride 5000 MG Granules for Oral Suspension [Colestid] RxCUI 1048452

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Colestipol 2685
    • Colestipol hydrochloride 104485
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Colestid 151533
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Colestipol Granules for Oral Suspension 2100170
    • Colestipol hydrochloride Granules for Oral Suspension 2646294
    • Colestipol Granule Product 1295303
    • Colestipol Oral Product 1155486
    • Colestipol hydrochloride Granule Product 2661704
    • Colestipol hydrochloride Oral Product 2663042
    • Colestipol Granules for Oral Suspension [Colestid] 2100172
    • Colestipol hydrochloride Granules for Oral Suspension [Colestid] 2655923
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Colestipol hydrochloride 5000 MG Granules for Oral Suspension SCD · 1048450
  • Colestipol hydrochloride 5000 MG SCDC · 1048449
  • Colestipol Granules for Oral Suspension SCDF · 2100170
  • Colestipol hydrochloride Granules for Oral Suspension SCDFP · 2646294
  • Colestipol Granule Product SCDG · 1295303
  • Colestipol Oral Product SCDG · 1155486
  • Colestipol hydrochloride Granule Product SCDGP · 2661704
  • Colestipol hydrochloride Oral Product SCDGP · 2663042

Brand-Name Concepts

  • Colestipol hydrochloride 5000 MG [Colestid] SBDC · 1048451
  • Colestipol Granules for Oral Suspension [Colestid] SBDF · 2100172
  • Colestipol hydrochloride Granules for Oral Suspension [Colestid] SBDFP · 2655923
  • Colestid Granule Product SBDG · 1296445
  • Colestid Oral Product SBDG · 1166289
  • Colestid BN · 151533

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1048452 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00009-0260-02 1 BOTTLE in 1 CARTON (0009-0260-02) / 500 g in 1 BOTTLE Colestid Pharmacia & Upjohn Company LLC 1977-06-01
00009-0260-17 1 BOTTLE in 1 CARTON (0009-0260-17) / 300 g in 1 BOTTLE Colestid Pharmacia & Upjohn Company LLC 1977-06-01
Observed labelers: Pharmacia & Upjohn Company LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.